{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:15:40Z","timestamp":1760267740331,"version":"3.37.3"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To establish, amongst Irish rheumatic musculoskeletal disease (RMD) patients, rates of COVID-19 symptoms and positive tests, DMARD adherence and attitudes to virtual clinics.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>An online survey assessing COVID-19 status, RMD diagnoses, adherence and information sources was disseminated via the Arthritis Ireland website and social media channels.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There were 1381 respondents with 74.8% on immunosuppressive medication. Symptoms of COVID-19 were reported by 3.7% of respondents of which 0.46% tested positive, consistent with the general Irish population. The frequency of COVID-19 symptoms was higher for respondents with spondyloarthropathy [odds ratio (OR) 2.06, 95% CI: 1.14, 3.70] and lower in those on immunosuppressive medication (OR 0.48, 95% CI: 0.27, 0.88), and those compliant with health authority (HSE) guidance (OR 0.47, 95% CI: 0.25, 0.89). Adherence to RMD medications was reported in 84.1%, with 57.1% using health authority guidelines for information on medication use. Importantly, adherence rates were higher amongst those who cited guidelines (89.3% vs 79.9%, P\u00a0&amp;lt;0.001), and conversely lower in those with COVID-19 symptoms (64.0% vs 85.1%, P\u00a0=0.009). Finally, the use of virtual clinics was supported by 70.4% of respondents.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The rate of COVID-19 positivity in RMD patients was similar to the general population. COVID-19 symptoms were lower amongst respondents on immunosuppressive medication and those adherent to medication guidelines. Respondents were supportive of HSE advice and virtual clinics.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa694","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T11:16:38Z","timestamp":1602242198000},"page":"902-906","source":"Crossref","is-referenced-by-count":20,"title":["COVID-19 and rheumatic musculoskeletal disease patients: infection rates, attitudes and medication adherence in an Irish population"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6201-8116","authenticated-orcid":false,"given":"Kieran","family":"Murray","sequence":"first","affiliation":[{"name":"The EULAR Centre for Arthritis and Rheumatic Disease, St Vincent\u2019s University Hospital, Elm Park and University College Dublin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1683-2226","authenticated-orcid":false,"given":"Sean","family":"Quinn","sequence":"additional","affiliation":[{"name":"The EULAR Centre for Arthritis and Rheumatic Disease, St Vincent\u2019s University Hospital, Elm Park and University College Dublin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9806-9644","authenticated-orcid":false,"given":"Matthew","family":"Turk","sequence":"additional","affiliation":[{"name":"The EULAR Centre for Arthritis and Rheumatic Disease, St Vincent\u2019s University Hospital, Elm Park and University College Dublin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3259-5390","authenticated-orcid":false,"given":"Anna","family":"O\u2019Rourke","sequence":"additional","affiliation":[{"name":"Infectious Diseases, St James University Hospital, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eamonn","family":"Molloy","sequence":"additional","affiliation":[{"name":"The EULAR Centre for Arthritis and Rheumatic Disease, St Vincent\u2019s University Hospital, Elm Park and University College Dublin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"The EULAR Centre for Arthritis and Rheumatic Disease, St Vincent\u2019s University Hospital, Elm Park and University College Dublin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann Barbara","family":"Mongey","sequence":"additional","affiliation":[{"name":"The EULAR Centre for Arthritis and Rheumatic Disease, St Vincent\u2019s University Hospital, Elm Park and University College Dublin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8084-0429","authenticated-orcid":false,"given":"Ursula","family":"Fearon","sequence":"additional","affiliation":[{"name":"Molecular Rheumatology, Trinity Biomedical Sciences Institute, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2802-4971","authenticated-orcid":false,"given":"Douglas J","family":"Veale","sequence":"additional","affiliation":[{"name":"The EULAR Centre for Arthritis and Rheumatic Disease, St Vincent\u2019s University Hospital, Elm Park and University College Dublin, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"year":"2020","key":"2021020119052585500_keaa694-B1"},{"key":"2021020119052585500_keaa694-B2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fpubh.2020.00152","article-title":"Gender differences in patients with COVID-19: focus on severity and mortality","volume":"8","author":"Jin","year":"2020","journal-title":"Front Public Health"},{"key":"2021020119052585500_keaa694-B3","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"Jama"},{"key":"2021020119052585500_keaa694-B4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMc2009567","article-title":"Covid-19 in immune-mediated inflammatory diseases\u2014case series from New York","volume":"383","author":"Haberman","year":"2020","journal-title":"N Engl J Med"},{"key":"2021020119052585500_keaa694-B5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/annrheumdis-2020-217424","article-title":"Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies","volume":"79","author":"Monti","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021020119052585500_keaa694-B6","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/art.41388","article-title":"Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?","volume":"72","author":"Favalli","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2021020119052585500_keaa694-B7","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","article-title":"Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2021020119052585500_keaa694-B8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/ard.2010.128637","article-title":"High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis","volume":"70","author":"Au","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021020119052585500_keaa694-B9","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1136\/annrheumdis-2016-210457","article-title":"Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials","volume":"76","author":"Cohen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021020119052585500_keaa694-B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-02894-7","article-title":"Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2","volume":"24","author":"Ingraham","year":"2020","journal-title":"Crit Care"},{"key":"2021020119052585500_keaa694-B11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa2016638","article-title":"A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19","volume":"383","author":"Boulware","year":"2020","journal-title":"N Engl J Med"},{"key":"2021020119052585500_keaa694-B12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"2021020119052585500_keaa694-B13"},{"key":"2021020119052585500_keaa694-B14","doi-asserted-by":"crossref","first-page":"e12855","DOI":"10.2196\/12855","article-title":"Readability and quality of online information on osteoarthritis: an objective analysis with historic comparison","volume":"8","author":"Murray","year":"2019","journal-title":"Interac J Med Res"},{"volume-title":"How to write easy-to-read health materials","year":"2017","key":"2021020119052585500_keaa694-B15"},{"key":"2021020119052585500_keaa694-B16","first-page":"294","article-title":"Patient and provider satisfaction with the use of telemedicine: overview and rationale for cautious enthusiasm","volume":"51","author":"Whitten","year":"2005","journal-title":"J Postgrad Med"},{"year":"2020","key":"2021020119052585500_keaa694-B17"},{"year":"2020","key":"2021020119052585500_keaa694-B18"},{"key":"2021020119052585500_keaa694-B19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1517\/14740338.2014.947260","article-title":"Adherence to therapy and adverse drug reactions: is there a link?","volume":"13","author":"Leporini","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"2021020119052585500_keaa694-B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-11-149","article-title":"Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review","volume":"11","author":"Garfield","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"2021020119052585500_keaa694-B21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"2021020119052585500_keaa694-B22","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2165\/11537400-000000000-00000","article-title":"Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices","volume":"28","author":"Shi","year":"2010","journal-title":"Pharmacoeconomics"},{"key":"2021020119052585500_keaa694-B23","article-title":"Concordance, adherence and compliance in medicine taking. National Co-ordinating Centre for","author":"Horne","year":"2005","journal-title":"NHS Service Delivery and Organisation"},{"key":"2021020119052585500_keaa694-B24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5694\/j.1326-5377.2006.tb00662.x","article-title":"Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2)","volume":"185","author":"Nelson","year":"2006","journal-title":"Med J Aust"},{"key":"2021020119052585500_keaa694-B25","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/rheumatology\/kem267","article-title":"Adherence to immunosuppressant drugs in patients with connective tissue diseases","volume":"46","author":"Pyne","year":"2007","journal-title":"Rheumatology"},{"year":"2020","key":"2021020119052585500_keaa694-B26"},{"key":"2021020119052585500_keaa694-B27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11162-004-1597-2","article-title":"Non-response in student surveys: the role of demographics, engagement and personality","volume":"46","author":"Porter","year":"2005","journal-title":"Res Higher Educ"},{"key":"2021020119052585500_keaa694-B28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1475-6773.2005.00350.x","article-title":"Response rates and response bias for 50 surveys of pediatricians","volume":"40","author":"Cull","year":"2005","journal-title":"Health Serv Res"},{"key":"2021020119052585500_keaa694-B29","doi-asserted-by":"crossref","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","volume":"109","author":"Rothan","year":"2020","journal-title":"J Autoimmun"},{"key":"2021020119052585500_keaa694-B30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41579-020-0332-0","article-title":"Outbreak of a novel coronavirus","volume":"18","author":"Du Toit","year":"2020","journal-title":"Nat Rev Microbiol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/2\/902\/36167949\/keaa694.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/2\/902\/36167949\/keaa694.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T03:04:41Z","timestamp":1612321481000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/2\/902\/5961490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,9]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,11,9]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa694","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"type":"print","value":"1462-0324"},{"type":"electronic","value":"1462-0332"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,11,9]]}}}